Potential involvement of S100A8/S100A9 and neutrophil extracellular traps in rheumatic heart disease valvular injury
Abstract
Rheumatic heart disease (RHD) causes immune-mediated valvular inflammation and fibrosis, but the contribution of neutrophil extracellular traps (NETs) remains unclear. We integrated mitral valve transcriptomics with histological, molecular and echocardiographic assessments in a rat RHD model. Transcriptomic analysis included four rats per group; each subsequent experiment included three rats per group. RHD valves showed inflammatory infiltration, collagen remodeling and increased S100A8/S100A9 expression, alongside enhanced myeloperoxidase (MPO) and citrullinated histone H3 (citH3) staining. S100A8/A9 and MPO showed partial local colocalization, whereas the measured echocardiographic parameters did not differ significantly between groups at the terminal assessment. Exploratory screening using nominal P < 0.05 and |log₂ fold change| > 1 identified 89 genes, nine of which overlapped a NET-related gene set. These included S100A8 and S100A9, with nominal P values of 0.009565 and 0.002586 and Benjamini–Hochberg-adjusted P values of 0.419214 and 0.297275, respectively. The combined findings support a possible contribution of S100A8/S100A9-associated NET responses to valvular inflammation and remodeling. However, the exploratory transcriptomic evidence, small experimental groups and absence of functional perturbation leave the proposed causal pathway in RHD unconfirmed.
Versions
Related
- Potential role of neutrophil extracellular traps in ovarian cancer-associated venous thrombosis
- Qingjin Desheng Pian attenuates NSCLC progression by suppressing neutrophil extracellular trap formation: involvement of the HMGB1/TLR2/MyD88 axis
- Abundant Glomerular Neutrophil Extracellular Traps in C3 Glomerulopathy
- Neutrophil Extracellular Traps at the Asthma + COPD Interface: Mechanisms, Experimental Models, and Therapeutic Targeting
- MyD88 Promotes Neutrophil Extracellular Trap Formation and Gut Leakiness After Ethanol and Burn Injury
BibTeX
@article{wen2026potential,
title = {{Potential involvement of S100A8/S100A9 and neutrophil extracellular traps in rheumatic heart disease valvular injury}},
author = {Jianlin Wen and Li Wang and Guangze Wu and Yuan Huang and Zhiyu Zeng},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-76532-7},
url = {https://www.nature.com/articles/s41598-026-76532-7},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Potential involvement of S100A8/S100A9 and neutrophil extracellular traps in rheumatic heart disease valvular injury
AU - Jianlin Wen
AU - Li Wang
AU - Guangze Wu
AU - Yuan Huang
AU - Zhiyu Zeng
PY - 2026
DA - 2026/10/14
JO - Scientific Reports
DO - 10.1038/s41598-026-76532-7
UR - https://www.nature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disease (RHD) causes immune-mediated valvular inflammation and fibrosis, but the contribution of neutrophil extracellular traps (NETs) remains unclear. We integrated mitral valve transcriptomics with histological, molecular and echocardiographic assessments in a rat RHD model. Transcriptomic analysis included four rats per group; each subsequent experiment included three rats per group. RHD valves showed inflammatory infiltration, collagen remodeling and increased S100A8/S100A9 expression, alongside enhanced myeloperoxidase (MPO) and citrullinated histone H3 (citH3) staining. S100A8/A9 and MPO showed partial local colocalization, whereas the measured echocardiographic parameters did not differ significantly between groups at the terminal assessment. Exploratory screening using nominal P < 0.05 and |log₂ fold change| > 1 identified 89 genes, nine of which overlapped a NET-related gene set. These included S100A8 and S100A9, with nominal P values of 0.009565 and 0.002586 and Benjamini–Hochberg-adjusted P values of 0.419214 and 0.297275, respectively. The combined findings support a possible contribution of S100A8/S100A9-associated NET responses to valvular inflammation and remodeling. However, the exploratory transcriptomic evidence, small experimental groups and absence of functional perturbation leave the proposed causal pathway in RHD unconfirmed.
SN - 2045-2322
ER -